Email this article An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity - PDF (English)
Copyright (c) 2022 Kostin N.N., Bobik T.V., Skryabin G.A., Simonova M.A., Knorre V.D., Abrikosova V.A., Mokrushina Y.A., Smirnov I.V., Aleshenko N.L., Kruglova N.A., Mazurov D.V., Nikitin A.E., Gabibov A.G.
This work is licensed under a Creative Commons Attribution 4.0 International License.